Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by Actavis Pharma, Inc., priced at $0.0983 per EA under NDC 00591042401. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 23, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591042401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA073449FDA Approved
9/23/1993
TE Code
AB
On Market Since
9/23/1993
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0983 per EA |
|---|---|
| All-time high | $0.1760 (Feb 12, 2014) |
| All-time low | $0.0721 (Nov 20, 2024) |
| 52-week high | $0.0983 |
| 52-week low | $0.0915 |
| Median price | $0.1088 |
| Average price | $0.1162 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by Actavis Pharma, Inc., is $0.0983 per EA (NDC 00591042401), effective Aug 19, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 41.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Since Nov 28, 2013, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0721 (Nov 20, 2024) to a high of $0.1760 (Feb 12, 2014), with a median of $0.1088 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, is $0.0963 per EA — about 2% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 00591042401) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.